Valesca Retel 2 Kleur Martinhogeboom 21 01 21

Valesca Retel

Valesca is endowed professor at the Erasmus University of Rotterdam, where she has a research chair called “HTA in translational research in oncology”. This chair has 3 pillars:

  1. Affordability
  2. Sustainability
  3. Timeliness

More about our research

Cost-effectiveness models

Health Technology Assessment

Team members

Valesca Retel 2 Kleur Martinhogeboom 21 01 21
Valesca Retel

Head of Health Technology Assessment / Group Leader
540355 Schaik Van
Lucas van Schaik

PhD Student
Zainab Al Khayat.
Zainab Al-Khayat

PhD student
545811 Burnod (002)
Sarah Burnod

PhD-student
Claudia Imaz
Claudia Imaz Lores

PhD-student
535216 Kramer
Astrid Kramer

Postdoctoral fellow
549761 Nies
Kelly Nies

Postdoc

Joana Rodrigues Braz De Carvalho
Joana Rodrigues Braz de Carvalho

PhD-student
Kevin Tittel
Kevin Tittel

PhD student
Madelon Voets
Madelon Voets

Postdoctoral fellow

Alumni

Melanie Lindenberg
Ann-Jean Beck
Danalyn Byng
Inge Eekhout
Julie Vancoppenolle
Joost Verbeek
Hester van de Wiel
Nora Franzen
Willeke Naaktgeboren

Publications of this group

Frontiers in pharmacology

Price transparency of cancer medicines: a crucial step towards informed pricing negotiations in the European region.

25-03-2026
Key Publication

BMJ open

Hospital-based real-world evidence in health technology assessment: insights from a scoping review of European, Australian and North American guidance and expert interviews.

31-12-2025
Key Publication

JAMA network open

Economic Evaluation of Comprehensive Genomic Profiling in an Advanced Solid Cancer Population.

01-12-2025
Key Publication

Nature medicine

Neoadjuvant ipilimumab and nivolumab in resectable cutaneous squamous cell carcinoma: a randomized phase 2 trial.

01-12-2025
Key Publication

Annals of oncology : official journal of the European Society for Medical Oncology

Health-related quality of life of patients with metastatic melanoma treated with tumor-infiltrating lymphocytes compared with ipilimumab in a randomized phase III trial.

01-10-2025
Key Publication

ESMO open

Financial toxicity and socioeconomic impact of cancer in Europe.

01-06-2025
Key Publication
More publications

Our collaborations

Banner Sabine Linn

Sabine Linn
Immune response to DCIS. The various types of immune cells are indicated by different colours, such as green, magenta, and red. DCIS is seen in the upper left part, indicated by the greyish cell borders.

Jelle Wesseling
Van Harten

Wim van Harten
The Haanen lab bridges fundamental, translational and clinical research

John Haanen
Bleiker

Eveline Bleiker

Contact our group

528845 Groenewegen
Danielle Groenewegen

Office Manager

Phone

Email

Karin Roede
Karin Roede

Office manager

Phone

Email

Disclaimer
Privacy statement
Cookies
Change cookie settings